Dr. Neal Goldstein provides a comprehensive overview on the following topics: the background science behind PD-L1 testing and PD1 therapy, the current status of anti-PD1 drugs, and recent updates regarding dMMR/MSI-high cancers in relation to anti-PD1 therapy.
Key Topics: PD-L1, MMR, MSI, anti-PD1 drugs